Mehrdad Mobasher's most recent trade in Corvus Pharmaceuticals Inc was a trade of 85,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 16, 2020.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Corvus Pharmaceuticals Inc | Mehrdad Mobasher | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2020 | 85,000 | 85,000 | - | - | Stock Option (Right to Buy) |